^
Association details:
Biomarker:SMAD4 deletion
Cancer:Head and Neck Cancer
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer

Published date:
02/10/2022
Excerpt:
In addition, SMAD4-deficient HPV-positive cells have increased sensitivity to cisplatin treatment....Moreover, we found that SMAD4 silencing in HPV-positive HNC cell lines increases sensitivity to cisplatin treatment, suggesting that HPV-positive HNC with low SMAD4 expression may be preferentially susceptible to similar treatments.
DOI:
10.1186/s13046-022-02258-9